The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT-Reference-Cited by-同舟云学术

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT

Published:2019-04-16 Issue:7 Volume:98 Page:1755-1763
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Schmidt-Hieber Martin,Tridello Gloria,Ljungman Per,Mikulska Malgorzata,Knelange Nina,Blaise Didier,Socié Gerard,Volin Liisa,Blijlevens Nicole,Fegueux Nathalie,Yakoub-Agha Ibrahim,Forcade Edouard,Maertens Johan,Chevallier Patrice,Passweg Jakob,Cornelissen Jan,Russell Nigel,Craddock Charles,Bourhis Jean Henri,Marchand Tony,Reményi Péter,Cahn Jean Yves,Michallet Mauricette,Montoto Silvia,Kröger Nicolaus,Glaß Bertram,Styczynski Jan

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03669-z.pdf

Reference39 articles.

1. Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J, Socié G, Schwerdtfeger R, Kröger N, Ganser A, Niederwieser D, Polge E, Blau IW, Mohty M (2013) CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood 122(19):3359–3364. https://doi.org/10.1182/blood-2013-05-499830

2. Jang JE, Hyun SY, Kim YD, Yoon SH, Hwang DY, Kim SJ, Kim Y, Kim JS, Cheong JW, Min YH (2012) Risk factors for progression from cytomegalovirus viremia to cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18(6):881–886. https://doi.org/10.1016/j.bbmt.2011.10.037

3. Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H, Boeckh M (2013) CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med 369(13):1227–1236. https://doi.org/10.1056/NEJMoa1303688

4. Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornhäuser M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, Kölling K, Stobernack HP, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Champlin RE, Ehninger G (2014) Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 370(19):1781–1789. https://doi.org/10.1056/NEJMoa1309533

5. Green ML, Leisenring W, Xie H, Mast TC, Cui Y, Sandmaier BM, Sorror ML, Goyal S, Özkök S, Yi J, Sahoo F, Kimball LE, Jerome KR, Marks MA, Boeckh M (2016) Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol 3(3):27–e127. https://doi.org/10.1016/S2352-3026(15)00289-6

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus infections – Swedish recommendations 2023;Infectious Diseases;2024-08-26

2. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation;Viruses;2024-08-08

3. Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia;Cytotherapy;2024-06

4. Comparative analysis of the impact of cytomegalovirus viremia between fully matched and haploidentical hematopoietic stem cell transplants in acute leukemia patients;The Egyptian Journal of Haematology;2024-04

5. Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience;Biotechnology & Biotechnological Equipment;2024-03-18